
Paragon 28 (FNA) Stock Forecast & Price Target
Paragon 28 (FNA) Analyst Ratings
Bulls say
Paragon 28 Inc is expected to achieve significant revenue growth, with projections suggesting an increase of over 17% over the next few years, driven by sales force expansion, new product launches, and market share gains. The company is anticipated to report full-year revenue for 2024 in the range of $255.9-$256.2 million, reflecting an approximate 18% year-over-year increase, which surpasses consensus expectations. Moreover, the continued momentum from nearly 80 product systems aimed at various foot and ankle procedures positions the company favorably for long-term profitability and reduced cash burn.
Bears say
Paragon 28 faces significant risks including slower-than-expected revenue growth, weaker EBITDA margins, and potential market share erosion due to competition from companies with advanced robotics systems. Additionally, the recent downgrade of FNA, as well as the less-than-expected acquisition price premium, suggests diminishing investor confidence and raises concerns about the company's strategic positioning in a competitive marketplace. The inclusion of a contingent value right (CVR) tied to specific revenue thresholds further indicates uncertainty regarding Paragon 28's future performance and profitability.
This aggregate rating is based on analysts' research of Paragon 28 and is not a guaranteed prediction by Public.com or investment advice.
Paragon 28 (FNA) Analyst Forecast & Price Prediction
Start investing in Paragon 28 (FNA)
Order type
Buy in
Order amount
Est. shares
0 shares